In the last 2 years I've sadly let bloggers and bashers cause me to sell PCYC, ACAD, INCY and STML and I left so much $$$ on table that it is painful. They bash INO and I've learned that when a company has cash, a pipe of products, and real management/board you just have to be patient through the days/weeks/months. There is no way Roche, Gates, the US Gov't, U of Penn, this board and management team are simply wasting time on INO. It is all very real and while no guarantees, the risk/reward is as good as it gets. Be patient.
I allowed myself to be shaken out of DYAX at 3.00 and PSDV at 1.20 when they were drifting down waiting for news. But those experiences taught me never to sell like that again. My only regret is that I don't have any cash right now to buy more INO if it gets beaten down below 2.00.
Completely agree with your statement. ACAD has moved solidly north since its phase III results. Patience is key to having huge gains with INO. In a couple of years we will look back at the enormous strides INO has made along with the PPS. As Steven would say, "Onward and Upward". GLTA!!!!